Vitamin A Discovery Rewrites How Sharp Vision Develops

For decades, scientists believed that the foveola — the tiny central region of the retina responsible for sharp color vision — achieves its specialized cone pattern because blue cones form and then migrate away. New research using lab-grown human retinal organoids shows this is not the case.

Instead, blue cone photoreceptors initially appear in the foveola during early fetal development but then transform into red and green cones through a precisely orchestrated process involving retinoic acid (a derivative of vitamin A) and thyroid hormones. Retinoic acid levels drop to halt new blue cone formation, while thyroid hormones drive the conversion of existing blue cones into red and green ones.

This discovery, published in Proceedings of the National Academy of Sciences, overturns a long-standing model and provides a clearer molecular mechanism for how humans develop high-acuity central vision. It also has implications for understanding diseases that damage the foveola, such as macular degeneration, and for improving retinal organoid models used in regenerative medicine and cell therapies.

This Ledger Entry expands how readers think about human development and regenerative medicine by revealing that the precise cone patterning in the foveola arises from cellular transformation orchestrated by retinoic acid and thyroid hormones — opening new avenues for understanding macular diseases and improving lab-grown retinal therapies.